Akoya Biosciences (AKYA)
(Delayed Data from NSDQ)
$2.88 USD
-0.03 (-1.03%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.90 +0.02 (0.69%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | 0.00% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.98 |
Next Year | -0.52 |
EPS (TTM) | -1.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 25.41M | 31.20M | 98.01M | 116.97M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 26.00M | 33.33M | 99.85M | 121.48M |
Low Estimate | 25.01M | 29.40M | 96.30M | 114.54M |
Year ago Sales | 25.22M | 26.49M | 96.63M | 98.01M |
Year over Year Growth Est. | 0.76% | 17.76% | 1.42% | 19.35% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.09 | -0.98 | -0.52 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.20 | -0.12 | -0.93 | -0.51 |
High Estimate | -0.16 | -0.04 | -0.86 | -0.38 |
Low Estimate | -0.20 | -0.12 | -1.07 | -0.60 |
Year ago EPS | -0.26 | -0.22 | -1.43 | -0.98 |
Year over Year Growth Est. | 26.92% | 59.09% | 31.47% | 46.33% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.09 | -0.98 | -0.52 |
7 Days Ago | -0.19 | -0.09 | -0.98 | -0.52 |
30 Days Ago | -0.19 | -0.09 | -0.99 | -0.57 |
60 Days Ago | -0.18 | -0.12 | -0.99 | -0.53 |
90 Days Ago | -0.18 | -0.12 | -0.99 | -0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.09 | -1.04 | -0.54 |
Zacks Consensus Estimate | -0.19 | -0.09 | -0.98 | -0.52 |
Earnings ESP | 0.00% | 0.00% | -6.56% | -3.45% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.35 | -0.22 | -0.26 | NA |
Estimate | -0.27 | -0.30 | -0.27 | -0.37 | NA |
Difference | 0.00 | -0.05 | 0.05 | 0.11 | 0.03 |
Surprise | 0.00% | -16.67% | 18.52% | 29.73% | 7.90% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more